SheerVision, Inc. (SVSO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2009 | -71.37 Thousand USD | 68.08% |
| 2008 | -223.6 Thousand USD | 75.3% |
| 2007 | -905.28 Thousand USD | 61.47% |
| 2006 | -2.34 Million USD | -2847.88% |
| 2005 | -79.69 Thousand USD | -5.31% |
| 2004 | -75.67 Thousand USD | 13.5% |
| 2003 | -87.49 Thousand USD | -190.36% |
| 2002 | -30.13 Thousand USD | -75.06% |
| 2001 | -17.21 Thousand USD | -36.7% |
| 2000 | -12.59 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2010 Q1 | -6323.00 USD | 92.06% |
| 2010 Q3 | 400.81 Thousand USD | 177.09% |
| 2010 Q2 | -519.94 Thousand USD | -8123.0% |
| 2009 Q3 | -62.49 Thousand USD | -1357.38% |
| 2009 Q1 | 65.8 Thousand USD | 3015.86% |
| 2009 Q4 | -79.64 Thousand USD | -27.45% |
| 2009 Q2 | 4970.00 USD | -92.45% |
| 2009 FY | -71.37 Thousand USD | 68.08% |
| 2008 Q3 | -90.52 Thousand USD | 41.59% |
| 2008 Q4 | 2112.00 USD | 102.33% |
| 2008 FY | -223.6 Thousand USD | 75.3% |
| 2008 Q1 | 19.78 Thousand USD | 75.19% |
| 2008 Q2 | -154.97 Thousand USD | -883.18% |
| 2007 Q3 | -193.25 Thousand USD | 51.39% |
| 2007 Q2 | -397.53 Thousand USD | -22.03% |
| 2007 Q1 | -325.76 Thousand USD | 68.22% |
| 2007 FY | -905.28 Thousand USD | 61.47% |
| 2007 Q4 | 11.29 Thousand USD | 105.84% |
| 2006 Q1 | -5702.00 USD | 20.55% |
| 2006 Q2 | -350.48 Thousand USD | -6046.67% |
| 2006 Q3 | -590.4 Thousand USD | -68.45% |
| 2006 FY | -2.34 Million USD | -2847.88% |
| 2006 Q4 | -1.02 Million USD | -73.63% |
| 2005 FY | -79.69 Thousand USD | -5.31% |
| 2005 Q1 | -22.31 Thousand USD | -27.77% |
| 2005 Q3 | -8213.00 USD | 74.09% |
| 2005 Q2 | -31.7 Thousand USD | -42.04% |
| 2005 Q4 | -7177.00 USD | 12.61% |
| 2004 Q4 | -17.46 Thousand USD | 40.23% |
| 2004 Q1 | -18.22 Thousand USD | -6.3% |
| 2004 Q2 | -11.09 Thousand USD | 39.13% |
| 2004 FY | -75.67 Thousand USD | 13.5% |
| 2004 Q3 | -29.22 Thousand USD | -163.51% |
| 2003 FY | -87.49 Thousand USD | -190.36% |
| 2003 Q4 | -17.14 Thousand USD | 5.63% |
| 2003 Q3 | -18.16 Thousand USD | 3.31% |
| 2003 Q2 | -18.78 Thousand USD | -2042.61% |
| 2003 Q1 | 967.00 USD | 103.62% |
| 2002 Q2 | -7471.00 USD | -872.6% |
| 2002 Q4 | -26.74 Thousand USD | -148.52% |
| 2002 FY | -30.13 Thousand USD | -75.06% |
| 2002 Q1 | 967.00 USD | 107.52% |
| 2002 Q3 | -10.76 Thousand USD | -44.06% |
| 2001 Q4 | -12.86 Thousand USD | -94.14% |
| 2001 Q3 | -6626.00 USD | -87.76% |
| 2001 Q2 | -3529.00 USD | 26.16% |
| 2001 Q1 | -4779.00 USD | -109.88% |
| 2001 FY | -17.21 Thousand USD | -36.7% |
| 2000 Q3 | -8784.00 USD | -521.22% |
| 2000 Q4 | -2277.00 USD | 74.08% |
| 2000 Q1 | -1252.00 USD | -9.73% |
| 2000 FY | -12.59 Thousand USD | 0.0% |
| 2000 Q2 | -1414.00 USD | -12.94% |
| 1999 Q4 | -1141.00 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 92.299% |
| Ansell Limited | 76.5 Million USD | 100.093% |
| Ansell Limited | 76.5 Million USD | 100.093% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 100.294% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 95.622% |
| Psykey, Inc. | -1.32 Million USD | 94.609% |
| ConvaTec Group Plc | 130.3 Million USD | 100.055% |
| ConvaTec Group Plc | 130.3 Million USD | 100.055% |
| Encision Inc. | -691.78 Thousand USD | 89.682% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 49.668% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 69.545% |
| Innovative MedTech Inc. | -7.93 Million USD | 99.101% |
| LifePoint, Inc. | -15.23 Million USD | 99.531% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 98.952% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 84.942% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 73.993% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 84.451% |
| SmileDirectClub, Inc. | -86.4 Million USD | 99.917% |
| Sector 10, Inc. | 7036.00 USD | 1114.44% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 100.004% |
| United Health Products, Inc. | -2.62 Million USD | 97.279% |
| Vasamed, Inc. | -4.88 Million USD | 98.54% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 97.012% |
| Yubo International Biotech Limited | -1.2 Million USD | 94.076% |